GT 00X
Alternative Names: ADCs - Glycotope/LegoChem Biosciences; GT-00X; GT-00X ADCLatest Information Update: 03 Aug 2022
At a glance
- Originator Glycotope; LegoChem Biosciences
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 12 Jul 2022 Antibody Drug Conjugate - Glycotope/LegoChem Biosciences is available for licensing as of 18 Jul 2022. http://www.glycotope.com
- 12 Jul 2022 Glycotope and LegoChem Biosciences enter into a research collaboration and license agreement to discover and develop antibody drug conjugates for cancer
- 12 Jul 2022 Early research in Cancer in Germany (Parenteral)